M
Monopar Therapeutics Inc. (MNPR)
NCM – Real Time Price. Currency in USD
87.68
+0.05 (0.06%)
At close: Jun 26, 2026, 4:00 PM EDT
85.93
-1.75 (-2.00%)
After-hours: Jun 26, 2026, 6:49 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
87.68
+0.05 (0.06%)
At close: Jun 26, 2026, 4:00 PM EDT
85.93
-1.75 (-2.00%)
After-hours: Jun 26, 2026, 6:49 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Company's cash reserves $52.5M significantly exceed its total debt $131.6K, ensuring strong financial flexibility
Total current assets $137.7M exceed Total current liabilities $2.5M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$3.5M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 56.04 | 6.05 | 10 | |
| Quick ratio | 56.04 | 5.63 | 10 | |
| Debt to Equity | 0.00 | 0.30 | 10 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A |
| Operating Income | -11M | -9M | -16M | -17M | -19M |
| Net Income | -11M | -8M | -16M | -14M | -15M |
| EBITDA | -11M | -9M | -16M | -17M | -19M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | -79.74 | 1.0 |
| Next quarter | N/A | -52.02 | 1.0 |
| Current year | N/A | -49.98 | 1.0 |
| Next year | N/A | -26.54 | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 25.15 | 28.13 | -3.07 | 7.8 |
| Y/Y | 999 | -48.3 | -21.04 | 38.66 | 5.5 |
| 3y average | 999 | -17.79 | 15.59 | -26.89 | 5.3 |
| 5y average | 999 | -22.65 | 1.44 | -27.28 | 3.8 |
| Weighted average score | 5.6 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |